Market World In-vitro Toxicology Testing Market Analysis | Page 3

Recently, PETA International Science Consortium Ltd. declared that it will offer all the equipment to laboratories
working on human-relevant models to substitute the application of animals in inhalation testing. This is
anticipated to aid in the adoption of these tests thereby supporting industry and regulatory scientists to gather
information without animal model implementation.
Regional Insights
In 2016, the largest share of approximately 45% was accounted by North America due of availability of favorable
government initiatives for development several laboratories in the particular region. Furthermore, animal
welfare organization also contributes to the adoption of these testing methods.
Furthermore, the fastest growth is accounted by Asia Pacific over the coming years because of increase of
government incentives for private and academic research work and augmentation of healthcare organization
thereby aiding in the adoption of this technology.
Competitive Insights
Major entities functioning in the market include Alere Inc., Eurofins Scientific, Cyprotex GE Healthcare, Charles
River Laboratories, Covance, Sigma-Alrich, Catalent Pharma Solutions and Thermo Fisher Scientific.
Participants are indulged in the advancement of software solutions so as to augment in-silico simulation
procedure for toxicological studies. These entities are also involved in enhancing the share by collaborating with
clinical research organizations and penetrating untapped regions across the globe.
Market Segments
End-use Outlook (Revenue, USD Billion; 2014 - 2025)
• Pharmaceutical industry
• Cosmetics & household products
• Diagnostics
• Chemical industry
• Food industry
Technology Outlook (Revenue, USD Billion; 2014 - 2025)
• Cell culture technology
• High throughput technology